BOZEN, SUD-TYROL, Italy, June 7 /PRNewswire/ -- Health Robotics announced that its joint-venture Health Robotics Canada Inc. (HRCI), a leading Canadian Pharmaceutical Company, and a well-established Quebec-based Medical Device Technology company have all recently signed marketing agreements in order to expand into Canada the market presence of i.v.STATION and i.v.SOFT, revolutionary technologies that provide automated sterile compounding of intravenous medications and parenteral nutrition to hospitals.
These new Canadian marketing contracts are highly complimentary of HRCI's recently announced multi-faceted partnership agreement with McKesson Automation, guaranteeing the sale, manufacturing, installation, and support of i.v.STATION and i.v.SOFT in North America. Today and tomorrow, McKesson Automation will showcase Health Robotics' products at Booth 701 of the American Society of Health-System Pharmacists' Summer Meeting (ASHP) in Tampa, Florida.
Gordon Meyer, Vice President, Hospital Division, Sandoz Canada Inc. stated, "As a leader in injectable drugs in Canada, our objective is to facilitate the safe and effective preparation and administration of injectable medications to ensure patient safety. With this marketing collaboration agreement with Sphynx Medical and Health Robotics, we hope to contribute to the development of business solutions to help our customers cope with some of the more interesting challenges in the hospital pharmacy."
The three parties are committed to facilitate the smooth integration of injectable vials with HRCI's products, ensuring that i.v.STATION and i.v.SOFT are optimized for the Canadian vial formats, vial sizes, vial labels, and specific gravity data, thus reducing the time and expense that Canadian hospitals experience in the installation and implementation of i.v.SOFT and i.v.STATION (showcased last week by NBC News Boston http://www1.whdh.com/video/player/?clipId=4834596).
"Everyone at Health Robotics is very proud to collaborate with these two market-leading Canadian companies, with one of the highest growth rates among the largest manufacturers of generic injectable pharmaceutical products in Canada and one of the most entrepreneurial Medical Device Technology companies in Canada," stated Werner Rainer, Health Robotics' CEO.
Denis Nadeau, President of Sphynx Medical Inc., concluded: "I foresee that the introduction of i.v.STATION and i.v.SOFT will dramatically improve the process of I.V. sterile preparations at Canadian hospitals, deriving at least similar clinical and financial benefits that I witnessed 20 years ago, when I led the market introduction of the first automated oral packaging device in Canada."
About Health Robotics:
Health Robotics is the undisputed global leading supplier of life-critical intra-venous medication robots, providing healthcare facilities in 5 continents with robotics technology and software automation solutions. Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs], i.v.SOFT(TM) [workflow engine for manual compounding, powered by MEDarchiver], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug-exchange errors, decrease other therapy oversights and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce nursing and pharmacy staff. For more information, please visit http://www.health-robotics.com
For additional information, please contact:
Health Robotics S.r.l.
Claudia Flaim, Marketing Coordinator
SOURCE Health Robotics